PetVivo Holdings, Inc. will present at the Spartan Capital Securities Second Annual Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. The company, which trades on OTCQX under the symbol PETV, specializes in biomedical therapeutics for equines and companion animals. This participation aligns with the conference's objective of highlighting innovative companies positioned for long-term growth.
John Lai, Chief Executive Officer of PetVivo Holdings, Inc., expressed enthusiasm about the opportunity to share the company's progress with investors and peers. The conference serves as a platform to strengthen relationships within the capital markets community and connect with new investors. Lai plans to provide an overview of PetVivo's operations and discuss its flagship products, SPRYNG with OsteoCushion Technology and PrecisePRP.
SPRYNG with OsteoCushion Technology represents an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles. These microparticles adsorb onto the joint synovial lining of animals and integrate with subsynovial tissue, promoting restoration of proper joint mechanics. This action aids in managing noninfectious sources of joint pain, including joint instability, degenerative joint disease, and osteoarthritis.
PrecisePRP stands as a first-in-class off-the-shelf platelet-rich plasma product designed for veterinary use. Unlike traditional PRP mechanical kits requiring blood draws and centrifugation, PrecisePRP offers a leucoreduced, allogeneic, pooled, freeze-dried formulation that provides species-specific concentrated platelets for intra-articular administration in dogs and horses. Each vial guarantees consistency with 4 billion platelets at a concentration of 500,000 platelets per microliter and leucoreduction maintaining fewer than 1500 white blood cells per microliter.
John D. Lowry, Founder and Chief Executive Officer of Spartan Capital Securities, LLC, emphasized the firm's commitment to connecting growth companies with appropriate investors and resources. The conference, organized in partnership with B2i Digital, will feature more than 60 companies across technology, healthcare, consumer, mining, precious metals, and other high-growth sectors. Over 500 institutional and high-net-worth investors are expected to attend the event, which includes main-stage presentations, expert panels, curated one-on-one meetings, and networking sessions.
David Shapiro, CEO of B2i Digital, noted that PetVivo's participation reflects their broader mission of combining digital marketing reach with face-to-face investor engagement. For additional information about the conference and registration details, interested parties can visit https://spartancapital.com. The event creates meaningful dialogue opportunities between growth companies and the investment community, supporting capital formation and market visibility for innovative enterprises like PetVivo Holdings.
